516 related articles for article (PubMed ID: 12370407)
21. Defective alloreactive CD8 T cell function and memory response in allograft recipients in the absence of CD4 help.
Zhai Y; Wang Y; Wu Z; Kupiec-Weglinski JW
J Immunol; 2007 Oct; 179(7):4529-34. PubMed ID: 17878349
[TBL] [Abstract][Full Text] [Related]
22. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy.
Chen Y; Heeger PS; Valujskikh A
J Immunol; 2004 May; 172(9):5456-66. PubMed ID: 15100287
[TBL] [Abstract][Full Text] [Related]
23. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen.
van Maurik A; Fazekas de St Groth B; Wood KJ; Jones ND
J Immunol; 2004 Feb; 172(4):2163-70. PubMed ID: 14764682
[TBL] [Abstract][Full Text] [Related]
24. Targeting LFA-1 and cd154 suppresses the in vivo activation and development of cytolytic (cd4-Independent) CD8+ T cells.
Lunsford KE; Koester MA; Eiring AM; Horne PH; Gao D; Bumgardner GL
J Immunol; 2005 Dec; 175(12):7855-66. PubMed ID: 16339521
[TBL] [Abstract][Full Text] [Related]
25. Contribution of CD40-CD154-mediated costimulation to an alloresponse in vivo.
Förster E; Krenger W; Joergensen J; Hof R; Geha RS; Holländer GA
Transplantation; 1999 May; 67(9):1284-7. PubMed ID: 10342324
[TBL] [Abstract][Full Text] [Related]
26. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
Cong L; Wang SF; Zhao ZL; Yang RY
Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
[TBL] [Abstract][Full Text] [Related]
27. Effects of preexisting autoimmunity on heart graft prolongation after donor-specific transfusion and anti-CD154.
Kalache S; Lakhani P; Heeger PS
Transplantation; 2014 Jan; 97(1):12-9. PubMed ID: 24056628
[TBL] [Abstract][Full Text] [Related]
28. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.
Yamada A; Salama AD; Sho M; Najafian N; Ito T; Forman JP; Kewalramani R; Sandner S; Harada H; Clarkson MR; Mandelbrot DA; Sharpe AH; Oshima H; Yagita H; Chalasani G; Lakkis FG; Auchincloss H; Sayegh MH
J Immunol; 2005 Feb; 174(3):1357-64. PubMed ID: 15661893
[TBL] [Abstract][Full Text] [Related]
29. Irinotecan combined with co-stimulatory molecule blockade prolongs survival of cardiac allografts in alloantigen-primed mice.
Zhang S; Chen Z; Yang R; Chen J; Cheng P; He Z; Liu Z; Qi Z
Cell Immunol; 2013 Apr; 282(2):85-92. PubMed ID: 23770716
[TBL] [Abstract][Full Text] [Related]
30. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307
[TBL] [Abstract][Full Text] [Related]
31. Different costimulatory and growth factor requirements for CD4+ and CD8+ T cell-mediated rejection.
Vu MD; Amanullah F; Li Y; Demirci G; Sayegh MH; Li XC
J Immunol; 2004 Jul; 173(1):214-21. PubMed ID: 15210777
[TBL] [Abstract][Full Text] [Related]
32. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
[TBL] [Abstract][Full Text] [Related]
33. CD154 on the surface of CD4+CD25+ regulatory T cells contributes to skin transplant tolerance.
Jarvinen LZ; Blazar BR; Adeyi OA; Strom TB; Noelle RJ
Transplantation; 2003 Nov; 76(9):1375-9. PubMed ID: 14627918
[TBL] [Abstract][Full Text] [Related]
34. Arsenic trioxide combined with co-stimulatory molecule blockade prolongs survival of cardiac allografts in alloantigen-primed mice.
Xu S; Chen J; Wang F; Kang X; Lan T; Wang F; Li Z; Qi Z; Xing J
Transpl Immunol; 2010 Oct; 24(1):57-63. PubMed ID: 20688163
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of recall responses through complementary therapies targeting CD8+ T-cell- and alloantibody-dependent allocytotoxicity in sensitized transplant recipients.
Zimmerer JM; Horne PH; Fiessinger LA; Fisher MG; Jayashankar K; Garcia SF; Abdel-Rasoul M; van Rooijen N; Bumgardner GL
Cell Transplant; 2013; 22(7):1157-69. PubMed ID: 23069206
[TBL] [Abstract][Full Text] [Related]
36. New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs.
Sho M; Sandner SE; Najafian N; Salama AD; Dong V; Yamada A; Kishimoto K; Harada H; Schmitt I; Sayegh MH
Ann Surg; 2002 Nov; 236(5):667-75. PubMed ID: 12409674
[TBL] [Abstract][Full Text] [Related]
37. New insights in CD28-independent allograft rejection.
Habicht A; Najafian N; Yagita H; Sayegh MH; Clarkson MR
Am J Transplant; 2007 Aug; 7(8):1917-26. PubMed ID: 17617854
[TBL] [Abstract][Full Text] [Related]
38. Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms.
Banuelos SJ; Markees TG; Phillips NE; Appel MC; Cuthbert A; Leif J; Mordes JP; Shultz LD; Rossini AA; Greiner DL
Transplantation; 2004 Sep; 78(5):660-7. PubMed ID: 15371665
[TBL] [Abstract][Full Text] [Related]
39. Neutralizing IL-7 promotes long-term allograft survival induced by CD40/CD40L costimulatory blockade.
Wang Y; Dai H; Liu Z; Cheng X; Tellides G; Dai Z
Am J Transplant; 2006 Dec; 6(12):2851-60. PubMed ID: 17062001
[TBL] [Abstract][Full Text] [Related]
40. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts.
Williams MA; Trambley J; Ha J; Adams AB; Durham MM; Rees P; Cowan SR; Pearson TC; Larsen CP
J Immunol; 2000 Dec; 165(12):6849-57. PubMed ID: 11120808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
